The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000860369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
26/06/2026
Date registered
Help: Date registered
14/07/2026
Date last updated
Help: Date last updated
14/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
14/07/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
The Effects of Traditional, Menstrual Cycle Phase-based, and Symptom Autoregulatory Resistance Training Prescription on Strength, Power, and Hypertrophy Adaptations in Healthy Female Adults
Scientific title
The Effects of Traditional, Menstrual Cycle Phase-based, and Symptom Autoregulatory Resistance Training Prescription on Strength, Power, and Hypertrophy Adaptations in Healthy Female Adults
Additional trial identifiers [1] 317692 0
None
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
The menstrual cycle 342566 0
Menstrual cycle-related symptoms 342774 0
Condition category
Condition code
Musculoskeletal 338717 338717 0 0
Normal musculoskeletal and cartilage development and function
Metabolic and Endocrine 338718 338718 0 0
Normal metabolism and endocrine development and function
Reproductive Health and Childbirth 338719 338719 0 0
Menstruation and menopause

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
This study aims to compare the effects of traditional training prescription (TRAD), menstrual cycle phase-based training prescription (MCP), autoregulatory prescription based upon perceived menstrual cycle symptoms (AUTO), and a free-living control (FLC) on changes in muscular strength, power, and hypertrophy across an eight-week training intervention in healthy females.

The study was a randomised controlled trial study design. For each participant, the study duration spanned four menstrual cycles, with participant's individual timeline determined by their menstrual cycle length. This included two baseline cycles, followed by two training cycles which involved 22 resistance training sessions completed across approximately eight weeks.

The training program followed a block periodisation model, which consisted of two four-week mesocycles of increasing volume, with an unloading week during each week of testing. The initial four weeks involved higher training volumes (e.g., 10 repetitions) performed at moderate intensities (i.e., 53-68% 1RM), while the subsequent four weeks emphasised maximal strength with moderate training volumes (e.g., 5 repetitions) performed at higher intensities (i.e., 61-80% 1RM). To align the training program with each participant’s menstrual cycle, the first training session of each block was initiated by the onset of menstrual bleeding, and testing occurred during the final week of the cycle. Furthermore, sessions were scheduled according to follicular and luteal phases, with the luteal phase starting the day after ovulation. A combination of calendar-based counting and urinary ovulation testing was used to determine follicular and luteal phases.
For the TRAD and MCP groups, all repetitions, sets, and intensities were prescribed for each exercise. However, the MCP group performed higher frequencies of training during the follicular phase and lower frequencies of training during the luteal phase of the menstrual cycle (i.e., eight sessions during the follicular phase and three sessions during the luteal phase), while the TRAD and AUTO groups performed a more even distribution of training frequencies in both phases (i.e., six sessions and five sessions, respectively). For the AUTO group, participants were allowed to manipulate session intensity ±4% or 8% of 1RM (which subsequently altered total volume) based upon their perceived menstrual cycle symptoms.

All training sessions lasted approximately 60 minutes and were supervised one-on-one by a qualified exercise professional. At least one day of rest was scheduled between sessions. However, due to interindividual variations in cycle and phase length, it was not always feasible to strictly adhere to this rest period between sessions. Each session consisted of six exercises, beginning with primary exercises (i.e., exercises that underwent 3RM strength testing; e.g., trap bar deadlift, bench press), followed by secondary compound exercises (e.g., split squats, shoulder press, rows) and auxiliary exercises (e.g., lateral raise, triceps extension, biceps curls). Training intensities for the primary exercises were prescribed using loads corresponding to a percentage of estimated 1RM. For secondary compound exercises, training was prescribed using the repetitions in reserve method, whereas auxiliary exercises were prescribed using repetition maximum zones. For all exercises, participants were instructed to control the eccentric phase and to execute the concentric portion using maximal intent.

Participants were required to complete >90% of the total number of workouts to be included in the analysis.
Intervention code [1] 334541 0
Treatment: Other
Description of the comparator or control
Free-living Control Group
Participants allocated to the free-living control (FLC) group did not receive any training intervention and continued their usual daily activities throughout the study period. However, participants were required to refrain from engaging in any structured resistance training program for the duration of the study.
Control group
Active

Outcomes
Primary outcome [1] 345940 0
3 Repetition Maximum (3RM) Strength: Trap Bar Deadlift
Timepoint [1] 345940 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Primary outcome [2] 345941 0
3RM Strength: Bench Press
Timepoint [2] 345941 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Primary outcome [3] 345943 0
3RM Strength: Prone Row
Timepoint [3] 345943 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [1] 463850 0
Isometric Mid-Thigh Pull (IMTP): Peak Force (Newtons)
Timepoint [1] 463850 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [2] 463851 0
Countermovement jump (CMJ): Jump height (cm)
Timepoint [2] 463851 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [3] 463852 0
Loaded CMJ: Jump height (cm)
Timepoint [3] 463852 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [4] 464640 0
CMJ: Average power (Watts)
Timepoint [4] 464640 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [5] 464641 0
Loaded CMJ: Average power (Watts)
Timepoint [5] 464641 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [6] 464642 0
CMJ: Peak power (Watts)
Timepoint [6] 464642 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [7] 464643 0
Loaded CMJ: Peak power (Watts)
Timepoint [7] 464643 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [8] 464644 0
30-Second Sprint Test: Average power (Watts)
Timepoint [8] 464644 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [9] 464645 0
30-Second Sprint Test: Peak power (Watts)
Timepoint [9] 464645 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [10] 464646 0
Vastus lateralis muscle thickness (cm)
Timepoint [10] 464646 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [11] 464647 0
Biceps Brachii muscle thickness (cm)
Timepoint [11] 464647 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [12] 464648 0
Triceps brachii muscle thickness (cm)
Timepoint [12] 464648 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [13] 464649 0
Bioelectrical Impedance Analysis: Body fat percentage (%)
Timepoint [13] 464649 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [14] 464650 0
Bioelectrical Impedance Analysis: Muscle mass (kg)
Timepoint [14] 464650 0
TRAD, MCP, and AUTO groups: Baseline (pre-intervention), mid-intervention (~4 weeks), and post-intervention (~8 weeks). FLC group: Baseline (pre-study) and post-study (~8 weeks).
Secondary outcome [15] 464651 0
Session Load (arbitrary units)
Timepoint [15] 464651 0
Calculated for each of the 22 training sessions completed over the intervention period.
Secondary outcome [16] 464652 0
Monotony (arbitrary units)
Timepoint [16] 464652 0
Calculated weekly over the intervention period.
Secondary outcome [17] 464653 0
Strain (arbitrary units)
Timepoint [17] 464653 0
Calculated weekly over the intervention period.

Eligibility
Key inclusion criteria
• Female, 18–40 years old.
• No existing health problems or circumstances that may inhibit ability to exercise or sleep. No medical condition that might increase the risk of an unusual adverse event after venous blood testing (e.g., bleeding or infection).
• Completed resistance training for at least six months, with a minimum of two training sessions per week during this period. However, this requirement did not apply to participants allocated to the free-living control group, for whom no prior resistance training experience was required.
• Naturally cycling (i.e., not using any form of hormonal contraception) with regular menstrual cycle lengths (21–35 days) and regular menstrual flow (2–7 days per cycle). Able to demonstrate evidence of a surge in luteinising hormone.
• Not known to be pregnant and not currently planning to become pregnant during the project. If there is reason to believe pregnancy may exist, a pregnancy test may be required before participation.
• No musculoskeletal injury diagnosed by a general medical practitioner (GP) or relevant specialist within the last six months.
Minimum age
18 Years
Maximum age
40 Years
Sex
Females
Healthy volunteers
Yes
Key exclusion criteria
• Participant has a diagnosed menstrual cycle dysfunction or disorder
• Participant is pregnant
• Participant has a diagnosed injury in the previous six months that would affect exercise performance

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation not concealed.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Block randomisation
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 322234 0
University
Name [1] 322234 0
Australian Catholic University
Country [1] 322234 0
Australia
Primary sponsor type
University
Name
Australian Catholic University
Address
Country
Australia
Secondary sponsor category [1] 325167 0
None
Name [1] 325167 0
Address [1] 325167 0
Country [1] 325167 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320758 0
ACU Human Research Ethics Committee
Ethics committee address [1] 320758 0
Ethics committee country [1] 320758 0
Australia
Date submitted for ethics approval [1] 320758 0
07/04/2022
Approval date [1] 320758 0
16/09/2022
Ethics approval number [1] 320758 0
2022-2639H

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151514 0
A/Prof Jonathon Weakley
Address 151514 0
Australian Catholic University, 1100 Nudgee Road, Banyo QLD 4014
Country 151514 0
Australia
Phone 151514 0
+61 414091852
Fax 151514 0
Email 151514 0
Contact person for public queries
Name 151515 0
Gabriella Munteanu
Address 151515 0
Australian Catholic University, 1100 Nudgee Road, Banyo QLD 4014
Country 151515 0
Australia
Phone 151515 0
+61434583040
Fax 151515 0
Email 151515 0
Contact person for scientific queries
Name 151516 0
Gabriella Munteanu
Address 151516 0
Australian Catholic University, 1100 Nudgee Road, Banyo QLD 4014
Country 151516 0
Australia
Phone 151516 0
+61434583040
Fax 151516 0
Email 151516 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.